We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Promising Opportunities for Cardiovascular Monitoring Equipment in Europe

By HospiMedica International staff writers
Posted on 03 Oct 2008
Technologically advanced, cost-effective cardiovascular monitoring systems are increasingly in demand in Europe. More...
The need for sophisticated, yet user-friendly equipment at affordable rates will offer market participants considerable growth opportunities in this sector.

These are the latest findings of Frost and Sullivan (Palo Alto, CA, USA), an international consulting firm. Cardiovascular diseases are one of the leading causes of premature death; furthermore, statistics have revealed that one in five teenagers suffers from the early signs of heart disease. Additionally, lifestyle changes and an aging population underpin the increasing incidence of cardiovascular-related illnesses. These trends are contributing to an increased need for diagnostic cardiovascular monitoring equipment, which are finding wider application in hospitals and cardiac rehabilitation centers to enable effective diagnosis and therapy.

However, while ECG is a well-established procedure, there have not been significant technologic breakthroughs in recent years and the market continues to persist with old technologies. This situation has been exacerbated by the lack of funds for the research and development of innovative technologies. Moreover, a persistent focus on treatment, rather than monitoring modalities, is threatening to impede market momentum. Market expansion is expected to be sustained by technological enhancements that promote greater user friendliness and improve networking and communication capabilities, while supporting cost efficiencies. In the future, growth opportunities will exist for companies that will be able to form strategic alliances to meet evolving end-user demands, despite intense competition among themselves.

"Larger participants have always had the upper hand because of their reputation and the superior brand awareness that they have been able to create. This is threatening the survival of smaller competitors,” said Frost & Sullivan research analyst Gideon V. Praveen Kumar.

Frost & Sullivan has found that the cardiovascular monitoring equipment market in Europe earned revenues of US$350 million in 2007 and estimates this to reach $491 million in 2014.

Related Links:
Frost and Sullivan



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Newborn Hearing Screener
ALGO 7i
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.